Nasdaq-listed company NewGenIVF invests an additional $4 million in K25.ai
According to Odaily, the Nasdaq-listed company NewGenIVF Group Limited has announced an additional strategic investment of $4 million in the AI-native live streaming prediction platform K25.ai. With this new round and previous funding combined, the company's total investment in the project rises to $6 million, giving K25.ai an implied post-investment valuation of $100 million. Following this strategic cooperation, K25.ai founder and CEO Andy Cheung, together with two co-founders, will join the NewGenIVF board. Reportedly, the newly raised funds will be fully used for platform R&D iteration, accelerating the integration of AI technology with live streaming, digital assets, and prediction market businesses. (PRNewswire)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Most panda coin types from the 2026 edition steadily rebounded in August
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage
Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.
2-Yr Benchmark Govt Yields - Germany vs Other Nations
2-Yr Benchmark Govt Yields - U.S. vs Other Nations
Crypto prices
More
